A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2004
12/22/2004	EP1487827A1 Anti-inflammatory morpholin-acetamide derivatives
12/22/2004	EP1487822A2 Pyrrole-2,5-dione derivatives and their use as gsk-3 inhibitors
12/22/2004	EP1487821A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
12/22/2004	EP1487807A2 New compounds
12/22/2004	EP1487805A1 Pyrimidine derivatives
12/22/2004	EP1487804A2 Aminoindazole derivatives as protein-kinase inhibitors
12/22/2004	EP1487801A1 7-arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo[d]azepine derivatives with 5-ht6 receptor affinity for the treatment of cns disorders
12/22/2004	EP1487800A1 Phenanthridinones as parp inhibitors
12/22/2004	EP1487793A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487778A1 Substituted 4-aminocyclohexanols
12/22/2004	EP1487776A1 Acid and ester compounds and methods of using the same
12/22/2004	EP1487494A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
12/22/2004	EP1487489A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN avb3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
12/22/2004	EP1487480A2 Fusion molecules and methods for treatment of immune diseases
12/22/2004	EP1487474A2 Intranasal administration of mc4-r agonists
12/22/2004	EP1487472A2 Stabilization of hypoxia inducible factor (hif) alpha
12/22/2004	EP1487471A2 Methods for treating autoimmune disorders and reagents related thereto
12/22/2004	EP1487469A1 Co-beadlet of dha and rosemary and methods of use
12/22/2004	EP1487446A2 Bicyclic heterocycles for the treatment of diabetes and other diseases
12/22/2004	EP1487444A1 Use of pyridyl amides as inhibitors of angiogenesis
12/22/2004	EP1487443A1 Heterocyclic amide derivatives for the treatment of diabetes and other diseases
12/22/2004	EP1487441A2 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
12/22/2004	EP1487431A1 Preventing and/or treating cardiovascular disease and/or associated heart failure
12/22/2004	EP1487427A1 Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline
12/22/2004	EP1487411A2 Inhalable sustained therapeutic formulations
12/22/2004	EP1487410A2 Preparation of sterile stabilized nanodispersions
12/22/2004	EP1487272A1 Choline-silicic acid complex with osmolytes and divalent trace elements
12/22/2004	EP1406894B1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity
12/22/2004	EP1333719A4 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
12/22/2004	EP1007043B9 Method for treatment of cns-involved lysosomal storage diseases
12/22/2004	EP0987254B1 Novel cyclic diamine compounds and medicine containing the same
12/22/2004	EP0732928B1 Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
12/22/2004	CN1556810A Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders
12/22/2004	CN1556809A Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives
12/22/2004	CN1556808A Heterocyclic compound based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosme
12/22/2004	CN1556805A Piperidine derivative as NMDA receptor antagonist
12/22/2004	CN1556804A 3-substituted-4-pyrimidone derivatives
12/22/2004	CN1556795A 3-desoxy-vitamin D3 analog esters
12/22/2004	CN1556716A Modular infusion device and method
12/22/2004	CN1556711A Use of thrombin-derived peptides for the therapy of chronic dermal ulcers
12/22/2004	CN1556706A Thieno [1,3] oxazin-4-ones with lipase inhibiting activity
12/22/2004	CN1556705A 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives
12/22/2004	CN1556703A 1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1 antagonistic activity
12/22/2004	CN1555887A Mineral composition and its manufacturing method
12/22/2004	CN1555865A Medicine for treating diabetes
12/22/2004	CN1555836A Ointment for emaciating body and its making method
12/22/2004	CN1555817A Medicine ginseng and astragalus yam paste for treating diabates and its preparation method
12/22/2004	CN1555815A Method of bological transforming selenium using bacillus bifidus and its product
12/22/2004	CN1555813A Compound formula chitin poly saccharid preparation
12/22/2004	CN1555811A Pearl lozenge
12/22/2004	CN1555786A Glymiurea dispersion tablet and its preparation method
12/22/2004	CN1181064C Process for preparing crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide
12/22/2004	CN1181050C Noval substituted dimeric compounds, its preparing process and medicinal composition containing same
12/22/2004	CN1180838C Chinese medicine for treating diabetes
12/22/2004	CN1180813C Fat-reducing weight-reducing chewing gum and is production method
12/22/2004	CN1180806C Pure Chinese medicine preparation for preventing and curing chicken infectious disease and its preparing process
12/22/2004	CN1180799C Deer fetus oral liquid and its preparation process
12/22/2004	CN1180785C Application of fur seal in preparation of medicine for treating diabetes
12/22/2004	CN1180767C Soluble liquid preparation of liposoluble matter
12/21/2004	US6833461 Process for preparing simvastatin
12/21/2004	US6833443 Gymnemic acid derivatives, process for the preparation thereof and use thereof as medicine
12/21/2004	US6833436 Short peptides which selectively modulate the activity of serine/threonine kinases
12/21/2004	US6833380 Compounds that modulate PPAR activity and methods of preparation
12/21/2004	US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders.
12/21/2004	US6833366 Alpha v beta 3 and/or 5 integrin antagonists; reduced side effects
12/16/2004	WO2004108907A1 Nerve cell obtained by electrically pulse-treating es cell
12/16/2004	WO2004108730A1 1h-imidazo`4,5-d!pyridazines as dpp-iv inhibitors for the treatment of niddm
12/16/2004	WO2004108729A1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF
12/16/2004	WO2004108709A1 Tetrazol benzofurancarboxamides with p13k aktivity as therapeutic agents
12/16/2004	WO2004108708A1 3-substituted indoles and derivatives thereof as therapeutic agents
12/16/2004	WO2004108698A1 Process for producing cyclic lactic acid oligomer having two-fold polymerization degree
12/16/2004	WO2004108678A1 (1,2,3,4-tetrahydroquinolin-8-yl)-heptatrienoic acid derivatives having serum glucose reducing activity
12/16/2004	WO2004108674A1 Amino alcohol derivative, medicinal composition containing the same, and uses of these
12/16/2004	WO2004108654A1 Chain lactic acid oligomer derivative and process for producing the same
12/16/2004	WO2004108161A1 Solid pharmaceutical preparation
12/16/2004	WO2004108064A2 Diosgenin-based composition suitable for topical application
12/16/2004	WO2004087206A3 Methods of treating diabetes by blocking vegf-mediated activity
12/16/2004	WO2004080448A3 Use of nep-associated molecules for treating non-immunogenic, non-hypertensive civilisation diseases
12/16/2004	WO2004072029A3 Pyrazolopyridazines useful as inhibitors of protein kinases
12/16/2004	WO2004070347A3 Screening for modulators of fat storage
12/16/2004	WO2004035740A3 Aromatic bicyclic heterocyles to modulate 1l - 12 production
12/16/2004	WO2003066666A3 Compositions and methods for treatment of vitamin d deficiency
12/16/2004	US20040254382 Imidazolyl derivatives as corticotropin releasing factor inhibitors
12/16/2004	US20040254370 Peroxisome proliferators activated receptor regulator; useful for hypoglycemia, hypolipidemia, preventing and/or treatment of diseases associating metabolic disorders, atherosclerosis, cardiovascular diseases, syndrome x, cholestrol
12/16/2004	US20040254362 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease
12/16/2004	US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders
12/16/2004	US20040254338 Melanin-concentrating hormone antagonists
12/16/2004	US20040254240 Anti-cancer nitro- and thia-fatty acids
12/16/2004	US20040254224 Medicaments
12/16/2004	US20040254216 Inhibitors of p38
12/16/2004	US20040254212 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
12/16/2004	US20040254210 Pharmaceutical compositions comprising colloidal silicon dioxide
12/16/2004	US20040254208 Compositions for affecting weight loss
12/16/2004	US20040254200 Antiinflammatory agents; controlling interleukins, tumor necrosis factor; antiarthritic agents; immunosuppressants
12/16/2004	US20040254198 Respiratory system disorders; asthma; chronic obstructive pulmonary disease
12/16/2004	US20040254185 Endothelial growth factor antagonist; angiogenesis inhibitor; skin disorders; anticancer agents; endometriosis; Crohn's disease; leukemia; antiarthritic agents; vision defects
12/16/2004	US20040254180 Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals
12/16/2004	US20040254176 Hypotensive agents; cardiovascular disorders; antidiabetic agents; skin disorders;kidney disorders; headaches; vision defects; strokes; synergistic mixture of amlodipine, benazepril and hydrochlorothiazide; oral administering
12/16/2004	US20040254167 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/16/2004	US20040254160 Benzothiazepine derivatives

1 ... 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 ... 1298